Docetaxel
NDC 45963-734, Docetaxel, injection, solution, concentrate, from Actavis Pharma, Inc..
- Product NDC
- 45963-734
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA203551
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45963-734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOCETAXEL20 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45963-734-54 | 45963073454 | 1 VIAL, GLASS in 1 CARTON (45963-734-54) / 1 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2c806400-5fdc-4398-8475-37f700b3191fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=45963-734
Use it
Look up 45963-734 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45963-734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45963-734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.